MedTrace Logo

Hormonal Contributors to COVID-19 Infection (COV-ENDO)

NCT05749770 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2025-09-02

No results posted yet for this study

Summary

The goal of this observational study is to measure the changes in the parameters of endocrine function and tissue sensitivity to hormones induced by SARs-CoV-2 infection.

The main questions it aims to answer are:

* Does SARs-CoV-2 infection causes endocrine dysfunctions?
* Does the treatment of the underlying endocrine dysfunctions, improves the clinical outcome or the occurrence of late onset complications of SARs-CoV-2 infection?
* Are patients with previously known endocrine diseases more fragile in case of SARs-CoV-2 infection? Participants will undergo blood testing and a physical examination at admission, during hospitalization at discharge and 3 and 6 moths after discharge They results will be compared to those of patients admitted for other reasons in order to assess whether the prevalence of endocrine dysfunctions is increased compared with controls.

Conditions

  • COVID-19 Pandemic
  • Endocrine System Diseases

Interventions

OTHER

blood testing

blood testing for basal hormones and markers of inflammation

Sponsors & Collaborators

  • Istituto Auxologico Italiano

    lead OTHER

Principal Investigators

  • Luca Persani, MD, PhD · Istituto Auxologico Italiano IRCCS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2023-12-31
Completion
2024-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05749770 on ClinicalTrials.gov